Maxcyte (MXCT) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to 0.84.
- Maxcyte's Equity Ratio fell 157.31% to 0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84, marking a year-over-year decrease of 157.31%. This contributed to the annual value of 0.86 for FY2024, which is 47.71% down from last year.
- Maxcyte's Equity Ratio amounted to 0.84 in Q3 2025, which was down 157.31% from 0.87 recorded in Q2 2025.
- Maxcyte's 5-year Equity Ratio high stood at 0.95 for Q3 2021, and its period low was 0.84 during Q3 2025.
- Its 5-year average for Equity Ratio is 0.88, with a median of 0.88 in 2024.
- Its Equity Ratio has fluctuated over the past 5 years, first surged by 4420.38% in 2021, then plummeted by 660.01% in 2022.
- Maxcyte's Equity Ratio (Quarter) stood at 0.93 in 2021, then fell by 4.25% to 0.89 in 2022, then fell by 2.32% to 0.87 in 2023, then decreased by 0.48% to 0.86 in 2024, then dropped by 1.95% to 0.84 in 2025.
- Its last three reported values are 0.84 in Q3 2025, 0.87 for Q2 2025, and 0.87 during Q1 2025.